| Total |
14,263 |
51.0 |
3,309 |
11.8 |
10,397 |
31.2 |
|
| Age |
59.64 |
17.4 |
58.91 |
16.2 |
59.61 |
16.9 |
0.070 |
| Sex |
|
|
|
|
|
|
<0.0001 |
| Male |
7,468 |
52.4 |
1,872 |
56.6 |
5,795 |
55.7 |
|
| Female |
6,795 |
47.6 |
1,437 |
43.4 |
4,602 |
44.3 |
|
| Year of Diagnosis |
|
|
|
|
|
|
<0.0001 |
| 2004-2006 |
4,195 |
29.4 |
789 |
23.8 |
3,326 |
32.0 |
|
| 2007-2009 |
4,936 |
34.6 |
1,147 |
34.7 |
3,585 |
34.5 |
|
| 2010-2012 |
5,132 |
36.0 |
1,373 |
41.5 |
3,486 |
33.5 |
|
| Race |
|
|
|
|
|
|
<0.0001 |
| White |
12,027 |
84.3 |
2,814 |
85.0 |
8,908 |
85.7 |
|
| Black |
1,490 |
10.5 |
353 |
10.7 |
925 |
8.9 |
|
| American Indian, Aleutian or Eskimo |
46 |
0.3 |
13 |
0.4 |
38 |
0.4 |
|
| Asian |
250 |
1.8 |
43 |
1.3 |
263 |
2.5 |
|
| Pacific Islander |
85 |
0.6 |
18 |
0.5 |
80 |
0.8 |
|
| Other |
120 |
0.8 |
24 |
0.7 |
65 |
0.6 |
|
| Unknown |
245 |
1.7 |
44 |
1.3 |
118 |
1.1 |
|
| Histology |
|
|
|
|
|
|
<0.0001 |
| Sarcoma, NOS |
2,477 |
17.4 |
1,036 |
31.3 |
2,168 |
20.9 |
|
| Ewing's sarcoma |
144 |
1.0 |
14 |
0.4 |
79 |
0.8 |
|
| Epithelioid sarcoma |
126 |
0.9 |
27 |
0.8 |
109 |
1.1 |
|
| High grade undifferentiated pleomorphic sarcoma |
1,470 |
10.3 |
499 |
15.1 |
1,806 |
17.4 |
|
| Fibrosarcoma |
1,330 |
9.3 |
291 |
8.8 |
1,126 |
10.8 |
|
| Solitary fibrous tumor |
121 |
0.9 |
17 |
0.5 |
58 |
0.6 |
|
| Dermatofibrosarcoma protuberans |
271 |
1.9 |
6 |
0.2 |
62 |
0.6 |
|
| Liposarcoma, NOS |
755 |
5.3 |
89 |
2.7 |
407 |
3.9 |
|
| Liposarcoma, well differentiated |
1,784 |
12.5 |
70 |
2.1 |
383 |
3.7 |
|
| Myxoid liposarcoma |
656 |
4.6 |
315 |
9.5 |
596 |
5.7 |
|
| Round cell liposarcoma |
53 |
0.4 |
22 |
0.7 |
92 |
0.9 |
|
| Pleomorphic liposarcoma |
209 |
1.5 |
104 |
3.1 |
324 |
3.1 |
|
| Dedifferentiated liposarcoma |
454 |
3.2 |
57 |
1.7 |
354 |
3.4 |
|
| Leiomyosarcoma |
2,416 |
16.9 |
356 |
10.8 |
1,319 |
12.7 |
|
| Vascular sarcoma |
533 |
3.7 |
23 |
0.7 |
283 |
2.7 |
|
| Rhabdomyosarcoma |
160 |
1.1 |
48 |
1.5 |
121 |
1.2 |
|
| Synovial sarcoma |
411 |
2.9 |
195 |
5.9 |
455 |
4.4 |
|
| Clear cell sarcoma |
54 |
0.4 |
2 |
0.1 |
18 |
0.2 |
|
| Chondrosarcoma |
342 |
2.4 |
35 |
1.1 |
127 |
1.2 |
|
| Malignant giant cell tumor |
21 |
0.2 |
1 |
0.0 |
11 |
0.1 |
|
| Malignant peripheral nerve sheath tumor |
468 |
3.3 |
98 |
3.0 |
484 |
4.7 |
|
| Alveolar soft part sarcoma |
8 |
0.1 |
4 |
0.1 |
15 |
0.1 |
|
| Grade |
|
|
|
|
|
|
<0.0001 |
| Grade 1 |
4,749 |
33.3 |
365 |
11.0 |
1,416 |
13.6 |
|
| Grade 2 |
2,600 |
18.2 |
514 |
15.5 |
1,737 |
16.7 |
|
| Grade 3 |
4,123 |
28.9 |
1,359 |
41.1 |
4,360 |
41.9 |
|
| Grade 4 |
2,791 |
19.6 |
1,071 |
32.4 |
2,884 |
27.7 |
|
| Tumor Size |
|
|
|
|
|
|
<0.0001 |
| <5 cm |
5,276 |
37.0 |
421 |
12.7 |
3,715 |
35.8 |
|
| 5-10 cm |
4,508 |
31.6 |
1335 |
40.2 |
3,817 |
36.7 |
|
| >10-15 cm |
2,074 |
14.6 |
843 |
25.4 |
1,650 |
16.0 |
|
| >15 cm |
2,045 |
17.0 |
710 |
21.4 |
1,215 |
11.8 |
|
| Charlson-Deyo Score |
|
|
|
|
|
|
<0.0001 |
| no comorbid conditions |
11,604 |
81.4 |
2,733 |
82.6 |
8,673 |
83.4 |
|
| 1 comorbid condition |
2,137 |
15.0 |
468 |
14.1 |
1,425 |
13.7 |
|
| >1 comorbid condition |
522 |
3.7 |
108 |
3.3 |
299 |
2.9 |
|
| Margins |
|
|
|
|
|
|
<0.0001 |
| R0 |
11,395 |
79.9 |
2,981 |
90.1 |
7,795 |
75.0 |
|
| R1 |
1,636 |
11.5 |
190 |
5.7 |
1,600 |
15.4 |
|
| R2 |
1,232 |
8.6 |
138 |
4.2 |
1,002 |
9.6 |
|
| Chemo |
|
|
|
|
|
|
<0.0001 |
| Not given |
12,342 |
86.5 |
2,247 |
67.9 |
8,353 |
80.3 |
|
| Given |
1,503 |
10.5 |
998 |
30.2 |
1,771 |
17.0 |
|
| Unknown |
418 |
2.9 |
64 |
1.9 |
273 |
2.6 |
|
| Facility Type |
|
|
|
|
|
|
<0.0001 |
| Community Cancer Program |
744 |
5.2 |
79 |
2.4 |
685 |
6.6 |
|
| Comprehensive Community Cancer Program |
3,876 |
27.2 |
608 |
18.4 |
3,279 |
31.5 |
|
| Academic/Research Program |
6,725 |
47.2 |
2,021 |
61.1 |
4,402 |
42.3 |
|
| Integrated Network Cancer Program |
828 |
5.8 |
141 |
4.3 |
638 |
6.1 |
|
| Other specified types of cancer program |
0 |
0.0 |
0 |
0.0 |
0 |
0.0 |
|
| Unknown |
2,090 |
14.7 |
460 |
13.9 |
1,393 |
13.4 |
|
